For the Inventor, By the Inventor

Enter assignee name

Manchester, United Kingdom

Avecia Limited

USPTO Granted Patents = 106

Trademarks = 20

Forward Citations = 851

Loading Chart...

Loading Chart...

123 inventors (with patents filed for the assignee):

Roy Bradbury (11 out of 43 patents)

Paul Wight (9 out of 30 patents)

Mark Kenworthy (9 out of 15 patents)

4. Dean Thetford (8 out of 89 patents)

5. Mark Holbrook (8 out of 22 patents)

6. Prahalad Manibhai Mistry (8 out of 30 patents)

7. Janette Watkinson (7 out of 8 patents)

8. Aidan Joseph Lavery (7 out of 11 patents)

9. David Alan Pears (6 out of 14 patents)

10. Mark Robert James (6 out of 19 patents)

11. Peter Gregory (6 out of 77 patents)

12. Kathryn Carr (6 out of 8 patents)

13. Prakash Patel (5 out of 35 patents)

14. John Christopher Padget (5 out of 47 patents)

15. Andrew John Blacker (5 out of 23 patents)

Core Competencies:

Phosphorothioate Oligonucleotides

Aryl Hydrazone

Phthalocyanine Inks

Trisazo Dyes

Chiral Organometallic Compounds

Ink-Jet Printing

Disazo Dyes

Polyurethane Compositions

Aqueous Polymer Compositions

Antimicrobial Polymers

Fluidizing Agents

Transfer Hydrogenation

106 patents: Sort by Forward Citations

1. 7227017 - Process for the preparation of phosphorothioate oligonucleotides (2007-06-05),

2. 7138548 - Process for the preparation of aryl hydrazone and aryl hydrazine (2006-11-21),

3. 7132531 - Reactor (2006-11-07),

4. 7070646 - Phthalocyanine based inks with absorption maxima in the near infra-red and visible spectrum (2006-07-04),

5. 7056376 - Printing process using specified AZO compounds (2006-06-06),

6. 7052538 - Trisazo dyes for ink jet printing (2006-05-30),

7. 7041161 - Trisazo dyes for ink jet printing (2006-05-09),

8. 7022876 - Preparation of mandelic acid derivatives (2006-04-04),

9. 7022833 - Process for the preparation of phosphorothioate triesters (2006-04-04),

10. 7022171 - Phthalocyanine compounds and ink compositions comprising the same (2006-04-04),

11. 7019158 - Chiral organometallic compounds for use in asymmetric synthesis (2006-03-28),

12. 7019127 - Solution phase synthesis of oligonucleotides (2006-03-28),

13. 7014696 - Compounds, compositions and uses (2006-03-21),

14. 6979364 - Metal chelate compounds and inks (2005-12-27),

15. 6969421 - Processes, compositions and compounds (2005-11-29),

Avecia Limited is a global leader in providing specialized solutions and technologies for the life sciences and chemical industries. With a strong focus on innovation and collaboration, Avecia offers a wide range of contract development and manufacturing services for pharmaceuticals, biotechnology, and specialty chemicals. The company's expertise lies in process development, analytical testing, formulation development, and manufacturing of active pharmaceutical ingredients (APIs), drug products, and fine chemicals. Avecia's commitment to quality, compliance, and customer satisfaction has established its reputation as a trusted partner to many leading pharmaceutical and chemical companies worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

106 Patents

#3 in Manchester

#160 in United Kingdom

#7,186 in the World

Manchester, United Kingdom

Avecia Limited

Forward Citations = 851

123 inventors:

Roy Bradbury (11 out of 43 patents)

Paul Wight (9 out of 30 patents)

Mark Kenworthy (9 out of 15 patents)

4. Dean Thetford (8 out of 89 patents)

5. Mark Holbrook (8 out of 22 patents)

Please report any incorrect information to support@idiyas.com

Loading…